Glenn Tong
Chief Executive Officer bei VGI HEALTH TECHNOLOGY LIMITED
Profil
Glenn Tong is currently the CEO, Managing Director & Executive Director at VGI Health Technology Ltd.
He was previously the Executive Chairman & Chief Executive Officer at Invictus BioPharma Ltd.
and the Chief Executive Officer & Managing Director at Gordagen Pharmaceuticals Pty Ltd.
Dr. Tong holds a doctorate degree from the University of Melbourne.
Aktive Positionen von Glenn Tong
| Unternehmen | Position | Beginn |
|---|---|---|
| VGI HEALTH TECHNOLOGY LIMITED | Chief Executive Officer | 19.12.2019 |
Ehemalige bekannte Positionen von Glenn Tong
| Unternehmen | Position | Ende |
|---|---|---|
| Gordagen Pharmaceuticals Pty Ltd. | Chief Executive Officer | - |
Invictus BioPharma Ltd.
 Invictus BioPharma Ltd. Pharmaceuticals: MajorHealth Technology Invictus Biopharma Ltd. develops and commercializes novel dietary supplements and prescription medicines based on natural products. It offers delayed onset muscle soreness, muscle recovery, exercise endurance, non-alcoholic fatty liver disease, non-alcoholic steato hepatitis , pancreatic cancer, hyperlipidaemia, hypertension and diabetes. The company is headquartered in Melbourne, Australia. | Chief Executive Officer | - |
Ausbildung von Glenn Tong
| University of Melbourne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VGI HEALTH TECHNOLOGY LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Invictus BioPharma Ltd.
Invictus BioPharma Ltd. Pharmaceuticals: MajorHealth Technology Invictus Biopharma Ltd. develops and commercializes novel dietary supplements and prescription medicines based on natural products. It offers delayed onset muscle soreness, muscle recovery, exercise endurance, non-alcoholic fatty liver disease, non-alcoholic steato hepatitis , pancreatic cancer, hyperlipidaemia, hypertension and diabetes. The company is headquartered in Melbourne, Australia. | Health Technology |
| Gordagen Pharmaceuticals Pty Ltd. |
